VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02685995

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02685995
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02685995. Randomized; quadruple masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2019-12 (actual). Results posted on 2021-02-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
Acronym
TDC
Condition
Renal Failure Chronic Requiring Hemodialysis
Condition
Chronic Renal Insufficiency
Intervention (Device)
VectorFlow TDC
Intervention (Device)
Palindrome TDC
Lead sponsor
University of Pennsylvania (class: other)
Collaborator
Teleflex (class: industry)
Collaborator
Arrow International (class: industry)

Record details

Record id
cardio:ct-nct02685995
Content hash
b048bb3a3edf00ea4e4844b2e9a49dc5251322a3d26451129a56ec8c9ec606e6